NVAX Stock – Novavax Stock Bearish By 20% In The Last 14 Days
Shares of Novavax dropped by a staggering 20.79% in 14 days from $217.8 to $172.52 at 20:53 EST on Thursday, after five consecutive sessions in a row of losses. NASDAQ Composite is jumping 0.37% to $13,632.84, following the last session’s upward trend,
Novavax’s last close was $171.74, 92.26% under its 52-week high of $331.68.
Novavax’s sales growth is 6826.3% for the ongoing quarter and 1558.1% for the next. The company’s growth estimates for the ongoing quarter is a negative 520.7% and positive 250% for the next.
Year-on-year quarterly revenue growth grew by 3072.2%, now sitting on 475.6M for the twelve trailing months.
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $172.52 at 20:53 EST, way below its 52-week high of $331.68 and way higher than its 52-week low of $14.38.
Novavax’s Moving Average
Novavax’s value is way below its 50-day moving average of $210.81 and way higher than its 200-day moving average of $149.03.
More news about Novavax.